RAC 2.92% $1.94 race oncology ltd

Ann: Zantrene highly effective in Melanoma preclinical study, page-27

  1. 6,742 Posts.
    lightbulb Created with Sketch. 1714
    As I saw the Ann drop on my walk with my dog, I started trembling with joy and excitement! What a gem of an Ann for investors and patients!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.